Research-literacy siteEducational evidence reviews only — not medical advice, not dosing guidance, not a protocol for human or animal use. Medical disclaimer.

PeptideStacks

Peptide Marketing Red Flags

A guide to the marketing patterns that recur across grey-market peptide content — and what each one usually conceals.

Educational research-literacy content only. Not medical advice, not dosing guidance, not sourcing advice, and not a protocol for human or animal use. See our responsible information policy.

Phrases to read carefully

  • “Clinically proven” — without a cited trial, this is a claim, not a fact. Ask: which trial? Where is it indexed?
  • “Doctor recommended” — which doctor? Recommended for what? Recommended in a regulated medical context, or for general use?
  • “99% pure means safe” — purity is not safety. See purity vs sterility.
  • “Research only, but here are human results” — a label of research-use with marketing aimed at end-users is exactly the borderline case the MHRA looks at.
  • Before/after photos — not evidence. Photographic evidence is not blinded, not controlled, and not randomised.
  • Celebrity / influencer claims — not evidence. May also be paid promotion.
  • “Fake” PubMed citations — citations that do not link to PubMed, link to the wrong paper, or quote a paper out of context. See fake citation tactics.
  • Exaggerated synergy claims — “works 10x better when combined” — usually inferred, not demonstrated. See synergy assumed vs demonstrated.
  • “No side effects” — every active compound has potential adverse effects. Absence of reported effects can reflect absence of monitoring.
  • “Used by elite athletes” — at the elite level peptides are heavily anti-doping-scrutinised. Casual use of this claim is a flag.

Visual / design red flags

  • Stock photos of laboratory glassware on a sales page that does not name a laboratory.
  • Photos of vials with no batch number or with an obviously edited label.
  • “Certified” or “approved” logos that link to nothing.
  • Countdown timers and scarcity tactics on a medicines-adjacent page.

What to do

If a peptide page claims a specific outcome, ask: where is the evidence, in what model, with what limitations, and is the claim framed as descriptive (“a 2019 study reported…”) or directive (“you will see…”)? On PeptideStacks we frame descriptively wherever possible, with conservative evidence grades.